Log in to save to my catalogue

DNA damage response signatures are associated with frontline chemotherapy response and routes of tum...

DNA damage response signatures are associated with frontline chemotherapy response and routes of tum...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_40cbbde56bd748bbaf0c60f5ee08af9f

DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer

About this item

Full title

DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer

Publisher

England: BioMed Central Ltd

Journal title

Molecular cancer, 2025-03, Vol.24 (1), p.90-19, Article 90

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

A hallmark of small cell lung cancer (SCLC) is its recalcitrance to therapy. While most SCLCs respond to frontline therapy, resistance inevitably develops. Identifying phenotypes potentiating chemoresistance and immune evasion is a crucial unmet need. Previous reports have linked upregulation of the DNA damage response (DDR) machinery to chemoresis...

Alternative Titles

Full title

DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_40cbbde56bd748bbaf0c60f5ee08af9f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_40cbbde56bd748bbaf0c60f5ee08af9f

Other Identifiers

ISSN

1476-4598

E-ISSN

1476-4598

DOI

10.1186/s12943-025-02291-0

How to access this item